# FDA Inspection 1266937 - AILEX PHARMACEUTICALS LLC - April 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/ailex-pharmaceuticals-llc/eaa2dfee-a896-4199-9419-9b143cfe042e
Source feed: FDA_Inspections

> FDA Inspection 1266937 for AILEX PHARMACEUTICALS LLC on April 16, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266937
- Company Name: AILEX PHARMACEUTICALS LLC
- Inspection Date: 2025-04-16
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Kansas City District Office

## Related Documents

- [FDA Inspection 1292250 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/ailex-pharmaceuticals-llc/62309591-486b-451b-8640-3fc57c9a83fd)
- [FDA Inspection 1292250 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/ailex-pharmaceuticals-llc/e485a29f-f718-4ef3-8bda-125fcbaf4e69)

Company: https://www.keypedia.com/companies/ailex-pharmaceuticals-llc/88b18998-66d3-4f34-b8bf-264ad98290c9

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79